Investor sentiment around artificial intelligence has weakened on the back of recent U.S. export curbs on AI chips — but Goldman is still bullish.
Investor sentiment around artificial intelligence has soured on the back of the U.S. government's recent export curbs on AI chips — but Goldman Sachs is still bullish. "While investor sentiment around AI is weaker of late especially following new U.S. regulations, we think global competition could make the introduction of AI to major industries a primary focus," the investment bank's analysts, led by Daiki Takayama, wrote in an Oct. 23 note.
is in Goldman's conviction list of stocks as it is "well positioned to capture the AI mega trend in the coming years," the bank said, citing its "leading chipmaking capabilities" and 60% share of the global foundry market. The bank added that is likely to beat its peers thanks to " growing demand for high performance computing semiconductors … despite a near-term outlook made choppier by weaker demand from the mobile and PC industries ." The bank has a 12-month price target of 725 New Taiwan dollars on the stock, giving it a potential upside of just over 33% from its Oct. 24 close. Here are some of the other stocks in Goldman's conviction list.
, Goldman's conviction list stocks in this category include Chinese tech giant Hon Hai Precision Industry and Japanese electronics manufacturing company Ibiden . It has a target price of NT$149 for Hon Hai — giving it around 52% potential upside — and 10,000 Japanese yen for Ibiden, or around 35.5% upside. Apple supplier Hon Hai — also known as Foxconn — is currently undergoing tax audits and on-site investigations by Chinese authorities on its land use.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
This under-the-radar consumer products stock could rally nearly 30%, Goldman Sachs saysThis consumer products manufacturer has a successful track record of market disruption and growth across categories, according to Goldman Sachs.
Read more »
Weight-loss drugs driving hedge fund consumer stock flows -Goldman SachsWeight-loss drugs driving hedge fund consumer stock flows -Goldman Sachs
Read more »
Weight-loss drugs driving hedge fund consumer stock flows -Goldman SachsHedge funds have been buying consumer staple stocks in Europe in October while dumping the sector in the U.S., driven by concerns about the impact of weight-loss drugs on food habits, Goldman Sachs showed in two different reports about trading flows.
Read more »
Why Apple could be the big winner in its rocky partnership with Goldman SachsThe march toward a tech-driven financial sector seems inevitable
Read more »
Goldman names Kamo as global head of dealmaking for financial sponsorsGoldman names Kamo as global head of dealmaking for financial sponsors
Read more »
With mortgage rates near 8%, Goldman Sachs sees home prices rebounding in 2024Goldman Sachs says mortgage rates will ‘remain elevated for the foreseeable future, dipping to just under 7% by the end of next year.’
Read more »